Coronary Stent Market Research Report: By Type (Bare-Metal Stents, Drug-Eluting Stents, and Bio Absorbable Stents), by Mode of Delivery (Balloon-Expandable Stents and Self-Expanding Stents), by End-User (Hospitals & Clinics) -Forecast Till 2027
Coronary Stent Market Overview
The worldwide Coronary Stent Market Size is estimated to rise to have a CAGR of 7.8% during the forecasted time frame of 2023.
You must know that Coronary stents are little stretchy cylinder-like gadgets used to grow the conduits of the patient to forestall blockage. A coronary stent is embedded into the supply route of a patient experiencing a coronary illness because of plaque development. It is utilized for enlarging the narrow corridors and helps diminish chest torment and the possibility of coronary failure. Due to the effective use and high demand for Coronary stents, the Market is expected to enhance its growth in the future period.
Coronary Stent Market Segmentation
Global coronary stent market segmentation is classified on the basis of mode of delivery, type, material, and end-user.
By type, the market segments into drug-eluting stents, bioabsorbable stents, and bare-metal stents.
By material, the market comprises cobalt chromium, metallic stents, stainless steels, platinum chromium, nickel titanium, and others.
By end-user, the market includes hospitals and clinics, ambulatory surgical centers, cardiac centers, and others.
By mode of delivery, the market divides into self-expanding and balloon-expandable stents.
Coronary Stent Market Regional Analysis
segments into North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa.
North America is the dominant region of the lot and is primarily driven by the surging patient population suffering from coronary heart diseases, an increasing pool of geriatric population, and growing investments in the healthcare sector. Latin America, on the other hand, is slated to be one of the fastest growing regional market owing to the rising demand for coronary heart disease treatment options and the availability of technologically advanced devices for diagnosis purposes.
With Germany and the UK being the major contributors, the European coronary stent market is expected to flourish in the forthcoming years. An increasing emphasis on the diagnosis and treatment of heart and other related diseases has majorly driven the market in this region. The increasing healthcare expenditure is another key contributor to the market’s growth.
Asia-Pacific stands out as the fastest growing market amongst all the mentioned regions. This projection can be primarily attributed to the increasing prevalence of cardiovascular diseases and a rising focus on performing early diagnosis and treatment of heart diseases. The Middle East & African region is forecasted to exhibit a slow and steady rise in the growth ladder. The regional market is starting to show positive signs with an increasing number of healthcare facilities offering treatments for chronic diseases and an increasing growth of the medical device sector, especially for diagnostic devices. In Africa, increasing awareness concerning coronary heart diseases is pushing the market growth herein.
Coronary Stent Market Competitive Landscape
Global Coronary Stent Market includes some highly noteworthy players including B. Braun Melsungen AG (Germany), MicroPort Scientific Corporation (China), Vascular Concepts (India), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Translumina GmbH (Germany), Biosensors International Group, Ltd. (Singapore), Meril Life Sciences Pvt. Ltd. (India), Elixir Medical Corporation (U.S.), Boston Scientific Corporation (U.S.), STENTYS SA (France), Medtronic plc (Ireland), Abbott Laboratories (U.S.), Reva Medical Inc. (U.S.), and others.
Coronary Stent Industry Overview
Feb 8th, 2019, CeloNova BioSciences, Inc. (CeloNova), an innovative global medical device leader, announced the signing of a three-year group purchasing agreement with HealthTrust for their new game-changing Coronary Stent named COBRA PzF(TM) NanoCoated Coronary Stent (NCS) System.
Feb 22nd, 2019, Biotronic announced the approval of Osiro, an ultrathin-strut coronary stent, from the US Food and Drug Administration for the treatment of coronary artery disease. It was approved in Europe eight years back and has been implanted upon millions of patients globally.
Get More Information on Coronary Stent Market Research Report – Forecast to 2023 @
related reports
Vertigo Treatment Market Research Report - Global Forecast till 2027
Pain Relief Medication Market Research Report - Global Forecast till 2027
Orthopedic Braces Market Research Report - Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services
Comentários